Kapat
Popüler Videolar
Moods
Türler
English
Türkçe
Popüler Videolar
Moods
Türler
Turkish
English
Türkçe
Current concepts and future developments in T-cell-based immunotherapy of AML
5:40
|
Loading...
Download
Lütfen bekleyiniz...
Type
Size
İlgili Videolar
Current concepts and future developments in T-cell-based immunotherapy of AML
5:40
|
The role of immunotherapy in the AML treatment landscape
3:47
|
Key targets and the future of immunotherapy in AML
2:48
|
New developments in AML treatment
1:54
|
Future role of CAR-T in AML
0:59
|
Challenges With CAR T-Cell Therapies in AML
0:39
|
Immuno-oncology: what is next for AML?
1:26
|
CD1c-restricted T cells as a potential immunotherapy for leukemia
2:58
|
What’s new in immunotherapy for AML?
5:15
|
Engineering multi-antigenic CAR T-cells for AML
2:03
|
Challenges in treating AML
1:07
|
Finding the right targets for CAR T-cell therapy in AML
1:41
|
DARIC33 CAR T-cells in AML
2:38
|
CAR T Cell Therapy in MDS/AML
1:31:25
|
What is immunotherapy for AML?
3:04
|
Dr. Perl on Challenges of Implementing Immunotherapy in AML
1:10
|
Insights into NKG2D-targeting CAR-T cells in R/R AML
1:30
|
AML: Vaccination, hypomethylation and CAR-T
1:32
|
Cancer Immunotherapy Workshop 2021 – Overview of HIFU's Effect on Immune Response
13:39
|
Challenges with immunotherapy in AML: on-target, off-tumor toxicity
2:05
|
Copyright. All rights reserved © 2025
Rosebank, Johannesburg, South Africa
